SCHEMBL31429081

SCHEMBL31429081

COCCOc1ccc(C=C2C(=O)c3ccccc3N2C(C)=O)cc1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.53
▸ ALDH1A1 P00352 6/20 0.53
▸ SMN1; SMN2 Q16637 5/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ FDPS P14324 4/20 0.46
▸ MEN1 O00255 5/20 0.44
▸ KMT2A Q03164 5/20 0.44
▸ POLB P06746 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ HPGD P15428 3/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ HSP90AA1 P07900 1/20 0.42
▸ LMNA P02545 3/20 0.42
▸ CASP3 P42574 2/20 0.42
▸ SENP8 Q96LD8 2/20 0.42
▸ SENP7 Q9BQF6 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31428917 0.92 MAPT (0.52) MAPTALDH1A1SMN1; SMN2MAPK1HTT
SCHEMBL30163547 0.88 ALDH1A1 (0.53) MAPTALDH1A1SMN1; SMN2MAPK1HTT
SCHEMBL31428792 0.87 ALDH1A1 (0.53) MAPTALDH1A1SMN1; SMN2MAPK1HTT
SCHEMBL30163485 0.87 MAPT (0.53) MAPTALDH1A1SMN1; SMN2MAPK1HTT
SCHEMBL31428963 0.87 MAPT (0.53) MAPTALDH1A1SMN1; SMN2MAPK1HTT
SCHEMBL31428790 0.86 ALDH1A1 (0.52) MAPTALDH1A1SMN1; SMN2MAPK1HTT
SCHEMBL31428961 0.85 MAPT (0.51) MAPTALDH1A1SMN1; SMN2MAPK1HTT
SCHEMBL31428485 0.85 LRRK2 (0.52) MAPTALDH1A1SMN1; SMN2MAPK1HTT
SCHEMBL31428731 0.84 MAPT (0.55) MAPTALDH1A1SMN1; SMN2MAPK1HTT
SCHEMBL31428740 0.83 ALDH1A1 (0.53) MAPTALDH1A1SMN1; SMN2MAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2025-03-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND BRAF, RAF1, NRAS MAPT 4513/4885ALDH1A1 2352/4885SMN1; SMN2 4832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback